Showing results (651-660 of 1,206) with videos related to
Sort By:
Pageof 121
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stentsCrochan J O'Sullivan, Giulio G Stefanini, Lorenz Räber, et al.European Heart Journal|February 15, 2008
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patientsMichael Billinger, Jonas Beutler, Keywan R Taghetchian, et al.Circulation|August 30, 2021
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled TrialDhanunjaya Lakkireddy, David Thaler, Christopher R Ellis, et al.JACC. Cardiovascular Interventions|February 25, 2012
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromesBindu Kalesan, Giulio G Stefanini, Lorenz Räber, et al.JACC. Cardiovascular Interventions|July 27, 2026
Timing of Bleeding and Ischemic Events in High-Bleeding Risk Patients Treated With 1-Month DAPTGuillaume Marquis-Gravel, Davide Cao, Dylan Taylor, et al.Journal of the American Heart Association|November 8, 2019
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting StentsJuan F Iglesias, Dik Heg, Marco Roffi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 20, 2019
Transcatheter aortic valve-in-valve implantation in degenerative rapid deployment bioprosthesesUri Landes, Danny Dvir, Wolfgang Schoels, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2017
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trialsSalvatore Cassese, Robert A Byrne, Peter Jüni, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 7, 2022
Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL studyRoberto Galea, Khalil Mahmoudi, Christoph Gräni, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 27, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.Pageof 121